Armodafinil Patent Expiration
Armodafinil is Used for promoting wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. It was first introduced by Nuvo Pharmaceuticals (Ireland) Dac
Armodafinil Patents
Given below is the list of patents protecting Armodafinil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuvigil |
US7132570 (Pediatric) | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Jun 18, 2024
(Expired) | Nuvo Pharms |
| Nuvigil |
US7297346 (Pediatric) | Pharmaceutical formulations of modafinil |
May 29, 2024
(Expired) | Nuvo Pharms |
| Nuvigil | US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Dec 18, 2023
(Expired) | Nuvo Pharms |
| Nuvigil | US7297346 | Pharmaceutical formulations of modafinil |
Nov 29, 2023
(Expired) | Nuvo Pharms |
| Nuvigil |
USRE37516 (Pediatric) | Acetamide derivative having defined particle size |
Apr 06, 2015
(Expired) | Nuvo Pharms |
| Nuvigil | USRE37516 | Acetamide derivative having defined particle size |
Oct 06, 2014
(Expired) | Nuvo Pharms |
Armodafinil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List